• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2019

View Archived Issues

Psychiatric risk genes can have distinct effects in different disorders

Read More

Mouse model devised to understand the potential of autophagy enhancers in treating ALS

Read More

FDA approves IND for phase I trial of TransThera's TT-00920 for heart failure

Read More

Hyper-sialylated IgG product M-254 well tolerated in healthy subjects in first-in-human trial

Read More

Topline data reported from phase II study of ARQ-151 in atopic dermatitis

Read More

Alnylam presents topline data from ILLUMINATE-A phase III study of lumasiran

Read More

Cerevance and Takeda collaborate to advance novel therapies for gastrointestinal disorders

Read More

KIN-8194 overcomes BTK C481S-mediated ibrutinib resistance in preclinical models

Read More

Peloton Therapeutics discloses new 5'-nucleotidase inhibitors

Read More

D-amino-acid oxidase inhibitors discovered at SyneuRx International

Read More

Roche patents bacterial DNA gyrase and/or DNA topoisomerase IV inhibitors

Read More

FronThera US Pharmaceuticals presents ENPP2 inhibitors

Read More

New analgesics identified at CerSci Therapeutics

Read More

Phase I results of intratumoral administration of tigilanol tiglate support further development

Read More

Pilot clinical results for ondansetron in patients with bipolar disorder and alcohol dependence

Read More

First-in-class RSK inhibitor PMD-026 shows promise for triple-negative breast cancer

Read More

New human autoinflammatory disease discovered

Read More

Adamas reports results of phase III study of ADS-5102 in MS with walking impairment

Read More

INB-03 phase I data support progression to phase II in breast cancer

Read More

Homology reports initial data from phase I/II study of HMI-102 gene therapy in PKU

Read More

DiaMedica initiates phase II study of DM-199 in chronic kidney disease

Read More

ARM-210 studied in new clinical trial for ryanodine receptor type 1-related myopathies

Read More

Phase Ib data on PXL-065 support progression to phase II for NASH

Read More

Nordic Nanovector receives funding to support Alpha37 program

Read More

BioInvent and MSD enter clinical trial collaboration to study BI-1206 with Keytruda in solid tumors

Read More

Proteostasis reports phase II topline data on CFTR modulator combinations in cystic fibrosis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe